AR and posterior cortical atrophy: However, with the duration of anti‐androgen therapy extending, the AR gradually obtains androgen‐independent activation, resulting in PCa from castration‐sensitive to castration‐resistant [6, 7, 8], making patients face an increased risk of metastasis and eventual death [9].